Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 31800 [2010-13414]
Download as PDF
31800
Federal Register / Vol. 75, No. 107 / Friday, June 4, 2010 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Fellowships and Dissertations.
Date: July 13, 2010.
Time: 1 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Serena P. Chu, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6154, MSC 9609,
Bethesda, MD 20892–9609, 301–443–0004,
sechu@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: May 27, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–13414 Filed 6–3–10; 8:45 am]
BILLING CODE 4140–01–P
[Docket No. FDA–2010–N–0215]
Substances Generally Recognized as
Safe Added to Food for Animals;
Notice of Pilot Program
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
AGENCY:
ACTION:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
Jkt 220001
Food and Drug Administration,
HHS.
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
srobinson on DSKHWCL6B1PROD with NOTICES
Dated: May 27, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Food and Drug Administration
BILLING CODE 4140–01–P
16:01 Jun 03, 2010
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Race-Based Social
Stress and Health in the MADICS
Longitudinal Study, University of Michigan
at Ann Arbor.
Date: June 25, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific
Review, National Institutes of Health, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, 1600
Executive Boulevard, Rm. 5B01, Bethesda,
MD 20892, (301) 435–8382,
hindialm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–13413 Filed 6–3–10; 8:45 am]
VerDate Mar<15>2010
would constitute a clearly unwarranted
invasion of personal privacy.
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is seeking
participants for a voluntary pilot
program whereby persons submit to
FDA notices of claims that a particular
use of a substance in food for animals
is exempt from the statutory premarket
approval requirements based on the
notifier’s determination that such use is
generally recognized as safe (GRAS).
FDA intends to evaluate these notices
and will inform each participant
(notifier) in writing either that the
notice provides a sufficient basis for the
GRAS determination or that FDA has
identified questions as to whether the
intended use of the substance is GRAS.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
DATES: Submit written requests to
participate in the pilot program
beginning June 4, 2010.
ADDRESSES: Submit written requests to
participate in the pilot program to the
Division of Animal Feeds (HFV–224),
Center for Veterinary Medicine, Food
and Drug Administration, 7519 Standish
Pl., Rockville, MD 20855.
FOR FURTHER INFORMATION CONTACT:
Geoffrey K. Wong, Center for Veterinary
Medicine (HFV–224), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–453–6879,
Geoffrey.wong@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
A. The 1958 Amendment
In 1958, in response to public concern
about the increased use of chemicals in
foods and food processing, Congress
enacted the Food Additives Amendment
(the 1958 amendment) to the Federal
Food, Drug, and Cosmetic Act (the act).
The 1958 amendment required that,
before a new additive could be used in
food, its producer must demonstrate the
safety of the additive to FDA. The 1958
amendment defined the terms ‘‘food
additive’’ (section 201(s) of the act (21
U.S.C. 321(s))) and ‘‘unsafe food
additive’’ (section 409(a) of the act (21
U.S.C. 348(a))), established a premarket
approval process for food additives
(section 409(b) through (h)), and
amended the food adulteration
provisions of the act to deem
adulterated any food that is, or bears or
contains, any food additive that is
unsafe within the meaning of section
409 (section 402(a)(2)(C) of the act (21
U.S.C. 342(a)(2)(C))).
In enacting the 1958 amendment,
Congress recognized that many
substances intentionally added to food
would not require formal premarket
review by FDA to assure their safety.
Congress thus adopted, in section 201(s)
of the act, a two-step definition of ‘‘food
additive.’’ The first step broadly
includes any substance, the intended
use of which results or may reasonably
be expected to result, directly or
indirectly, in its becoming a component
or otherwise affecting the characteristics
of food. The second step, however,
excludes from the definition of ‘‘food
additive’’ substances that are generally
recognized, among experts qualified by
scientific training and experience to
evaluate their safety (‘‘qualified
experts’’), as having been adequately
shown through scientific procedures (or,
in the case of a substance used in food
prior to January 1, 1958, through either
scientific procedures or through
E:\FR\FM\04JNN1.SGM
04JNN1
Agencies
[Federal Register Volume 75, Number 107 (Friday, June 4, 2010)]
[Notices]
[Page 31800]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13414]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Race-Based Social Stress and
Health in the MADICS Longitudinal Study, University of Michigan at
Ann Arbor.
Date: June 25, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Michele C. Hindi-Alexander, PhD, Division of
Scientific Review, National Institutes of Health, Eunice Kennedy
Shriver National Institute of Child Health and Human Development,
1600 Executive Boulevard, Rm. 5B01, Bethesda, MD 20892, (301) 435-
8382, hindialm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: May 27, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-13414 Filed 6-3-10; 8:45 am]
BILLING CODE 4140-01-P